MAN2B1 and central nervous system cancer: Two recent RNA sequencing-based bioinformatic analytical studies have identified MAN2B1 as a novel prognostic biomarker for glioma, indicating that higher expression of MAN2B1 correlates with shorter survival times among patients [20, 79].